Detalhe da pesquisa
1.
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
N Engl J Med
; 384(20): 1899-1909, 2021 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951374
2.
Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis.
Pharmacogenet Genomics
; 33(6): 126-135, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37306344
3.
A Randomized Clinical Trial of Human Papillomavirus Test-and-Treat as Compared to Cytology-Based Screening for Prevention of Cervical Cancer Among Women With Human Immunodeficiency Virus: AIDS Clinical Trials Group Protocol A5282.
Clin Infect Dis
; 75(8): 1280-1288, 2022 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35294524
4.
Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size.
Clin Infect Dis
; 75(10): 1781-1791, 2022 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35396591
5.
Pharmacogenetics of interaction between depot medroxyprogesterone acetate and efavirenz, rifampicin, and isoniazid during treatment of HIV and tuberculosis.
Pharmacogenet Genomics
; 32(1): 24-30, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34369424
6.
Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial.
Lancet
; 395(10231): 1195-1207, 2020 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32145827
7.
Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate in African Women Receiving Treatment for Human Immunodeficiency Virus and Tuberculosis: Potential Concern for Standard Dosing Frequency.
Clin Infect Dis
; 71(3): 517-524, 2020 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31504342
8.
Distal Sensory Peripheral Neuropathy in Human Immunodeficiency Virus Type 1-Positive Individuals Before and After Antiretroviral Therapy Initiation in Diverse Resource-Limited Settings.
Clin Infect Dis
; 71(1): 158-165, 2020 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31630166
9.
Diverse Human Immunodeficiency Virus-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited Settings.
Clin Infect Dis
; 71(7): e170-e177, 2020 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31724034
10.
Human Immunodeficiency Virus-associated Neurocognitive Impairment in Diverse Resource-limited Settings.
Clin Infect Dis
; 68(10): 1733-1738, 2019 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30219843
11.
Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study.
J Infect Dis
; 217(3): 405-412, 2018 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29244111
12.
HIV and COPD: a conspiracy of risk factors.
Respirology
; 21(7): 1166-72, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27237114
13.
Antiretroviral therapies in women after single-dose nevirapine exposure.
N Engl J Med
; 363(16): 1499-509, 2010 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-20942666
14.
Incidence and Predictors of Pregnancy in Women Enrolled in Large Multinational HIV Treatment Trials of the AIDS Clinical Trials Group.
J Acquir Immune Defic Syndr
; 94(5): 461-467, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37820116
15.
Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens.
Contraception
; 121: 109951, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36641094
16.
Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings.
J Acquir Immune Defic Syndr
; 94(2): 165-173, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37368929
17.
Tuberculosis control.
Lancet
; 387(10024): 1157-8, 2016 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27025326
18.
Diet in a global cohort of adults with HIV at low-to-moderate traditional cardiovascular disease risk.
AIDS
; 36(14): 1997-2003, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35876637
19.
Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial.
Lancet HIV
; 9(9): e638-e648, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055295
20.
Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trial.
J Int AIDS Soc
; 25(6): e25905, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36039892